Cure Parkinson’s and Alzheimer’s Research UK announce a partnership
Cure Parkinson’s and Alzheimer’s Research UK are working on an initiative that could pave the way for innovative neurodegenerative treatments. There is a growing recognition that tackling neurodegenerative diseases could benefit from a collaborative, cross-disease approach. We are recognising the overlap in underlying biological...
Learn more
New funding opportunity: Combination therapies for Parkinson’s
Cure Parkinson’s is excited to announce that we are now accepting expressions of interest for our new combination therapy funding call. In August, Cure Parkinson’s announced we would be opening a £2 million funding call later this year to encourage the testing of combination therapies…
Dr Matthew Farrer wins 2025 Tom Isaacs Award
Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr Matthew Farrer as the winner of the 2025 Tom Isaacs Award, which honours researchers who closely collaborate with the Parkinson’s community. The two organisations were delighted to announce Dr Matthew Farrer as winner…
Combination therapies: a change in approach for Parkinson’s research
As part of our research strategy, Cure Parkinson’s is seeking to progress research involving combination therapies as a potential method for targeting Parkinson’s progression. Currently, clinical trials of potentially disease-modifying therapies for Parkinson’s are largely focussed on testing single drugs, or monotherapies. These drugs often…
Could ambroxol help to slow cognitive change in people with Parkinson’s?
The results of a phase 2 clinical trial of ambroxol in Canada for people with Parkinson’s dementia were published recently, finding it was safe and tolerable when taken by participants. A proportion of people with Parkinson’s experience cognitive changes – changes to our memory, thinking,…
New registry Join Parkinson’s Research aims to boost awareness and accessibility of clinical research studies for Parkinson’s
The Join Parkinson’s Research (JPR) registry is a new online platform where people living with the condition can register to hear about the latest clinical studies. Clinical research studies are vital to improve our understanding of Parkinson’s and help develop new treatments. However, due to…